Ignite Creation Date:
2024-05-06 @ 6:23 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05641545
Status:
TERMINATED
Last Update Posted:
2022-12-07
First Post:
2022-05-02
Brief Title:
IVAC-RCC-001 A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in AdvancedMetastatic RCC Patients
Sponsor:
SLK Kliniken Heilbronn GmbH
Organization:
SLK Kliniken Heilbronn GmbH
Organization Data
Organization:
SLK Kliniken Heilbronn GmbH
Class:
OTHER
Study ID:
IVAC-RCC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SLK Kliniken Heilbronn GmbH
Lead Sponsor Class:
OTHER
Responsible Party:
Uwe Martens
Responsible Party Title:
Director of the Department of Hematology Oncology and Palliative Care
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
SLK Kliniken Heilbronn GmbH
Old Name:
None
Old Organization:
None